These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33118020)

  • 1. Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori.
    Tehlan A; Karmakar BC; Paul S; Kumar R; Kaur I; Ghosh A; Mukhopadhyay AK; Dhar SK
    FEMS Microbiol Lett; 2020 Nov; 367(21):. PubMed ID: 33118020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
    Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
    Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic resistance of Helicobacter pylori].
    Wang F; Shen SR; Zhou JD; Xu CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Osaki T; Mabe K; Zaman C; Yonezawa H; Okuda M; Amagai K; Fujieda S; Goto M; Shibata W; Kato M; Kamiya S
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28544222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
    Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
    Lee JH; Shin JH; Roe IH; Sohn SG; Lee JH; Kang GH; Lee HK; Jeong BC; Lee SH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1600-3. PubMed ID: 15793150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
    Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
    J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of Helicobacter pylori susceptibility to rifaximin].
    Quesada M; Sanfeliu I; Junquera F; Segura F; Calvet X
    Gastroenterol Hepatol; 2004; 27(7):393-6. PubMed ID: 15461936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
    Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
    Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
    Perez Aldana L; Kato M; Nakagawa S; Kawarasaki M; Nagasako T; Mizushima T; Oda H; Kodaira J; Shimizu Y; Komatsu Y; Zheng R; Takeda H; Sugiyama T; Asaka M
    Helicobacter; 2002 Oct; 7(5):306-9. PubMed ID: 12390210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides.
    Kocsmár É; Buzás GM; Szirtes I; Kocsmár I; Kramer Z; Szijártó A; Fadgyas-Freyler P; Szénás K; Rugge M; Fassan M; Kiss A; Schaff Z; Röst G; Lotz G
    Nat Commun; 2021 Apr; 12(1):2255. PubMed ID: 33859206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi locus sequence typing (MLST) used as a tool to confirm the ability of susceptible Helicobacter pylori strains to gain resistance to clarithromycin during eradication therapy.
    Skvarc M; Kofol R; Samo J; Kopitar AN; Tepes B; Ihan A
    Hepatogastroenterology; 2014; 61(129):226-31. PubMed ID: 24895826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication.
    De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D
    J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet Digital PCR-Based Detection of Clarithromycin Resistance in Helicobacter pylori Isolates Reveals Frequent Heteroresistance.
    Sun L; Talarico S; Yao L; He L; Self S; You Y; Zhang H; Zhang Y; Guo Y; Liu G; Salama NR; Zhang J
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
    Yang YJ; Wu CT; Ou HY; Lin CH; Cheng HC; Chang WL; Chen WY; Yang HB; Lu CC; Sheu BS
    Ann Med; 2017 Sep; 49(6):479-486. PubMed ID: 28266875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
    Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.
    Feng ZH; Fan L; Yang J; Huo XY; Guo Y; Zhang Y; Lan CH
    BMC Microbiol; 2019 Aug; 19(1):176. PubMed ID: 31382897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.